, Oct. 15
/PRNewswire/ -- CoreLab Partners, Inc
, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA
"We are pleased to announce that we have formally launched state-of-the-art imaging solutions to address the numerous indications and therapeutic areas of drug development requiring DXA imaging sciences," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "The addition of DXA services to our growing list of modalities is a natural extension of our broad range of services as CoreLab Partners continues to expand its global reach and reputation for excellence across its cross-section of core lab services under our newly combined entity," added Woehler.
This important launch correlates with the opening of the American Society of Bone Mineral Research (ASBMR) conference which will take place from October 15-19, 2010 at the Metro Toronto Convention Centre in Toronto, ON. Please visit CoreLab Partners at booth number #1507 to learn more about this exciting addition to their global suite of imaging sciences solutions and cardiac safety services.
About CoreLab Partners, Inc
CoreLab Partners, with offices in North America, Europe and Asia, provides complete medical image assessment services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. CoreLab Partners also provides solutions for the collection, analysis and management of cardiac safety and efficacy information during drug development. Driven by best-in-class science, technology, and service quality, CoreLabs is a global leader providing ECG, TQT, Holter, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry, and Pulse Wave Analysis.
Kevin D. Duffy
Vice President, Global Business Development
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
SOURCE CoreLab Partners, Inc